Literature DB >> 12325041

Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex.

Craig W Berridge1, Thomas A Stalnaker.   

Abstract

Despite the well-known and potent arousal-enhancing effects of amphetamine (AMPH)-like stimulants, the neurobiological substrates of AMPH-induced arousal have rarely been examined explicitly. Available evidence suggests the possible participation of noradrenergic and/or dopaminergic systems in the arousal-enhancing actions of AMPH-like stimulants. The current studies examined the extent to which low-dose AMPH-induced increases in waking are related to AMPH-induced increases in extracellular norepinephrine (NE) and dopamine (DA) levels within the prefrontal cortex (PFC), as measured by in vivo microdialysis. Vehicle injections elicited brief epochs of waking. Vehicle-induced waking was closely associated with a brief and moderate (50% above baseline) increase in NE levels. DA levels were less sensitive to the arousing actions of vehicle injections, with maximal increases of approximately 25% above baseline observed. 0.15 mg/kg and 0.25 mg/kg AMPH increased time spent awake, which resulted primarily from increases in quiet waking. Although the magnitude of the waking response did not differ substantially between the two doses across time, a trend for a more rapid recovery to baseline waking levels was observed at the higher dose, possibly suggesting the development of a relatively rapid-onset tolerance to the wake-promoting actions of AMPH at this dose. At the 0.15 mg/kg dose, AMPH elicited maximum increases of approximately 175% and 125% above baseline levels for NE and DA, respectively. The time course of AMPH-induced increases in waking closely paralleled the time course of AMPH-induced increases in both NE and DA efflux. These observations are consistent with the hypothesis that both increased DA and NE efflux contribute to the low-dose behavioral effects of AMPH-like stimulants, including the arousal-enhancing actions of these drugs. Additionally, these observations also suggest a possibly greater sensitivity of NE efflux, relative to DA, to moderately arousing conditions including low-dose AMPH-like stimulant administration. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12325041     DOI: 10.1002/syn.10131

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  26 in total

1.  Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat.

Authors:  Michael H Baumann; Zakia Williams; Dorota Zolkowska; Richard B Rothman
Journal:  Drug Alcohol Depend       Date:  2010-11-10       Impact factor: 4.492

Review 2.  Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder.

Authors:  Craig W Berridge; David M Devilbiss
Journal:  Biol Psychiatry       Date:  2010-09-26       Impact factor: 13.382

3.  Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent atomoxetine treatment.

Authors:  Britahny M Baskin; Bríd Á Nic Dhonnchadha; Linda P Dwoskin; Kathleen M Kantak
Journal:  Psychopharmacology (Berl)       Date:  2017-07-20       Impact factor: 4.530

4.  Amphetamine Exerts Dose-Dependent Changes in Prefrontal Cortex Attractor Dynamics during Working Memory.

Authors:  Christopher C Lapish; Emili Balaguer-Ballester; Jeremy K Seamans; Anthony G Phillips; Daniel Durstewitz
Journal:  J Neurosci       Date:  2015-07-15       Impact factor: 6.167

5.  A thalamocorticostriatal dopamine network for psychostimulant-enhanced human cognitive flexibility.

Authors:  Gregory R Samanez-Larkin; Joshua W Buckholtz; Ronald L Cowan; Neil D Woodward; Rui Li; M Sib Ansari; Catherine M Arrington; Ronald M Baldwin; Clarence E Smith; Michael T Treadway; Robert M Kessler; David H Zald
Journal:  Biol Psychiatry       Date:  2012-12-27       Impact factor: 13.382

6.  Tolcapone suppresses ethanol intake in alcohol-preferring rats performing a novel cued access protocol.

Authors:  Aqilah M McCane; Cristine L Czachowski; Christopher C Lapish
Journal:  Alcohol Clin Exp Res       Date:  2014-09       Impact factor: 3.455

Review 7.  The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex.

Authors:  Robert C Spencer; David M Devilbiss; Craig W Berridge
Journal:  Biol Psychiatry       Date:  2014-09-28       Impact factor: 13.382

8.  6-hydroxydopamine lesions enhance progesterone-facilitated lordosis of rats and hamsters, independent of effects on motor behavior.

Authors:  Cheryl A Frye; Sandra M Petralia; Madeline E Rhodes; Joseph F DeBold
Journal:  Physiol Behav       Date:  2009-09-22

9.  Effects of low dose cocaine on REM sleep in the freely moving rat.

Authors:  Clifford M Knapp; Subimal Datta; Domenic A Ciraulo; Conan Kornetsky
Journal:  Sleep Biol Rhythms       Date:  2007-01       Impact factor: 1.186

10.  The effects of clinically relevant doses of amphetamine and methylphenidate on signal detection and DRL in rats.

Authors:  Matthew E Andrzejewski; Robert C Spencer; Rachel L Harris; Elizabeth C Feit; Brenda L McKee; Craig W Berridge
Journal:  Neuropharmacology       Date:  2014-01-24       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.